Monash scientists have provided new insights into the role of protein and cholesterol in diet which may have implications for
Continue reading »Home »
Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia
SUMMIT, N.J. & CAMBRIDGE, Mass.–July 9, 2018 (BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today
Continue reading »